Skip to main content
. Author manuscript; available in PMC: 2017 Jun 26.
Published in final edited form as: Am J Med. 2013 Apr 15;126(6):541.e1–541.e14. doi: 10.1016/j.amjmed.2012.11.030

Table 3.

Differences* in Anemia Management Parameters for Bolus and Maintenance Dose Users (Mean and 95% CI)

Parameter Hemoglobin Epogen TSAT Ferritin
Week 02 0.2 (0.17, 0.22) 46 (−67, 158) -- --
Week 04 0.23 (0.21, 0.26) −463 (−583, −343) 3.31 (2.99, 3.63) 151.8 (134.9, 168.7)
Week 06 0.2 (0.17, 0.23) −883 (−1010, −757) -- --
*

Fully adjusted model: covariates included : EPO dose during exposure period, age, sex, race, baseline hemoglobin, ferritin, index TSAT; pneumonia, vascular access infection, sepsis in baseline; any infection in last month; most recent vascular access is catheter, vintage, albumin, baseline EPO dose, baseline iron dose; history of diabetes, stroke, myocardial infarction, chronic obstructive pulmonary disease, cancer, gasterointestinal bleeding in baseline; hospital days in past month; body mass index